Sunshine Biopharma Inc (SBFM)’s financial ratios: A comprehensive overview

The closing price of Sunshine Biopharma Inc (NASDAQ: SBFM) was $0.06 for the day, up 6.14% from the previous closing price of $0.06. In other words, the price has increased by $+0.0035 from its previous closing price. On the day, 21216411 shares were traded.

Ratios:

Our analysis of SBFM’s different ratios will help us gain a deeper understanding of the company. For the most recent quarter (mrq), Quick Ratio is recorded 3.45 and its Current Ratio is at 4.48. In the meantime, Its Debt-to-Equity ratio is 0.03 whereas as Long-Term Debt/Eq ratio is at 0.03.

Insider Transactions:

Also, insider trades can serve as a great indicator of what management thinks about the future direction of a stock’s price. A recent insider transaction in this stock occurred on Mar 04 ’24 when Slilaty Steve N. bought 100,000 shares for $0.10 per share. The transaction valued at 10,000 led to the insider holds 130,000 shares of the business.

Slilaty Steve N. bought 20,000 shares of SBFM for $2,000 on Feb 08 ’24. The Chief Executive Officer now owns 30,000 shares after completing the transaction at $0.10 per share.

Valuation Measures:

Investors should consider key stock statistics when deciding whether to invest or divest. In the wake of the recent closing price, SBFM now has a Market Capitalization of 5.95M and an Enterprise Value of -12.22M. For the stock, the TTM Price-to-Sale (P/S) ratio is 0.25 while its Price-to-Book (P/B) ratio in mrq is 0.08. Its current Enterprise Value per Revenue stands at -0.60 whereas that against EBITDA is 0.47.

Stock Price History:

Over the past 52 weeks, SBFM has reached a high of $1.40, while it has fallen to a 52-week low of $0.04. The 50-Day Moving Average of the stock is 0.1227, while the 200-Day Moving Average is calculated to be 0.3088.

Shares Statistics:

SBFM traded an average of 15.50M shares per day over the past three months and 6.65M shares per day over the past ten days. A total of 99.45M shares are outstanding, with a floating share count of 91.94M. Insiders hold about 7.55% of the company’s shares, while institutions hold 11.83% stake in the company. Shares short for SBFM as of Mar 15, 2024 were 970.97k with a Short Ratio of 0.06, compared to 602.57k on Feb 15, 2024. Therefore, it implies a Short% of Shares Outstanding of 0.98% and a Short% of Float of 1.02%.

Earnings Estimates

The firm’s stock currently is rated by 1 analysts. The consensus estimate for the next quarter is -$0.08, with high estimates of -$0.08 and low estimates of -$0.08.

Analysts are recommending an EPS of between -$0.16 and -$0.16 for the fiscal current year, implying an average EPS of -$0.16. EPS for the following year is $0.09, with 1 analysts recommending between $0.09 and $0.09.

Revenue Estimates

Based on 1 analysts’ estimates, the company’s revenue will be $44.4M in the next fiscal year. The high estimate is $44.4M and the low estimate is $44.4M. The average revenue growth estimate for next year is up 84.30% from the average revenue estimate for this year.

Most Popular

[the_ad id="945"]